Medtronic plc announces new codes as Medtronic plc stock trades at EUR 77.24
Published on 10/03/2026 at 10:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Medtronic plc announced on October 1, 2026, that the American Medical Association approved new Category I CPT codes for its Altaviva and Symplicity Spyral systems, according to the company’s press release. Medtronic plc stock was at EUR 77.24 in weekend trading at Lang & Schwarz at 10:24 a.m. CEST on October 3, 2026.
Weekend trading
The EUR 77.24 price was EUR 0.02 below the EUR 77.26 close of the last Xetra trading day at Lang & Schwarz on October 2, 2026, a change of minus 0.03 percent. The bid was EUR 77.08 and the ask was EUR 77.40. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CEST is shown by the continuously updated real-time quote of Medtronic plc stock.
Last Xetra close
Lang & Schwarz recorded a close of EUR 77.26 for Medtronic plc on October 2, 2026. The reference close is separate from the weekend-trading indication on October 3, 2026.
New reimbursement codes
The October 1 announcement said the new Category I codes will replace existing Category III codes and become effective in January 2028. The approval covers Medtronic’s Altaviva implantable tibial neuromodulation device for urge urinary incontinence and its Symplicity Spyral renal denervation system for uncontrolled hypertension. The company said Category I coding can support physician payment and inform commercial payer coverage decisions, but does not determine coverage, reimbursement, clinical superiority or patient access. These details are from Medtronic’s release.
Next Xetra session
The next Xetra session is scheduled for October 5, 2026.
